LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Iterum Therapeutics plc and Millions of Other Companies

Sign up for full access to Iterum Therapeutics plc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Anti-Infective Specialization Iterum Therapeutics plc specializes in developing novel anti-infective compounds to combat multi-drug resistant pathogens globally, presenting a unique opportunity for healthcare institutions struggling with resistant infections.

Product Efficacy Iterum's anti-infective compound has shown potent in-vitro activity against various bacteria resistant to traditional antibiotics, offering a compelling solution to healthcare providers seeking effective treatment options for challenging infections.

Technology Integration Utilizing tech tools like Google Analytics, jQuery, and PWA indicates Iterum's commitment to leveraging digital solutions, making them an attractive partner for healthcare organizations looking to modernize their approaches to infectious disease management.

Financial Backing With a recent funding of $35M, Iterum Therapeutics has the financial stability to support R&D efforts, offering a potential collaboration opportunity for investors or institutions interested in breakthrough solutions for antibiotic-resistant infections.

Competitive Landscape In comparison to similar companies like BerGenBio ASA and Nabriva Therapeutics plc, Iterum's focused approach and product efficacy position them as a strong contender in the anti-infective market, indicating potential for strategic partnerships or market expansion.

Similar companies to Iterum Therapeutics plc

✕

Access Insights for Iterum Therapeutics plc and Millions of Other Companies

Sign up for full access to Iterum Therapeutics plc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Iterum Therapeutics plc Tech Stack

Iterum Therapeutics plc uses 8 technology products and services including Google Analytics, Modernizr, jQuery, and more. Explore Iterum Therapeutics plc's tech stack below.

  • Google Analytics
    Analytics
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • PWA
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Open Graph
    Miscellaneous
  • FedEx
    Transportation And Fleet Management
  • Apache
    Web Servers

Media & News

Iterum Therapeutics plc's Email Address Formats

Iterum Therapeutics plc uses at least 1 format(s):
Iterum Therapeutics plc Email FormatsExamplePercentage
Last@iterumtx.comDoe@iterumtx.com
44%
FLast@iterumtx.comJDoe@iterumtx.com
41%
First@iterumtx.comJohn@iterumtx.com
13%
First.Last@iterumtx.comJohn.Doe@iterumtx.com
2%

Frequently Asked Questions

Where is Iterum Therapeutics plc's headquarters located?

Minus sign iconPlus sign iconIterum Therapeutics plc's main headquarters is located at Harcourt Street Dublin 2, Dublin 2 IE. The company has employees across 2 continents, including North AmericaEurope.

What is Iterum Therapeutics plc's stock symbol?

Minus sign iconPlus sign iconIterum Therapeutics plc is a publicly traded company; the company's stock symbol is ITRM.

What is Iterum Therapeutics plc's official website and social media links?

Minus sign iconPlus sign iconIterum Therapeutics plc's official website is iterumtx.com and has social profiles on LinkedIn.

What is Iterum Therapeutics plc's NAICS code?

Minus sign iconPlus sign iconIterum Therapeutics plc's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Iterum Therapeutics plc have currently?

Minus sign iconPlus sign iconAs of September 2024, Iterum Therapeutics plc has approximately 21 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: C. F.Owner: S. A.Cfo: J. M.. Explore Iterum Therapeutics plc's employee directory with LeadIQ.

What industry does Iterum Therapeutics plc belong to?

Minus sign iconPlus sign iconIterum Therapeutics plc operates in the Pharmaceutical Manufacturing industry.

What technology does Iterum Therapeutics plc use?

Minus sign iconPlus sign iconIterum Therapeutics plc's tech stack includes Google AnalyticsModernizrjQueryPWAMicrosoftOpen GraphFedExApache.

What is Iterum Therapeutics plc's email format?

Minus sign iconPlus sign iconIterum Therapeutics plc's email format typically follows the pattern of . Find more Iterum Therapeutics plc email formats with LeadIQ.

How much funding has Iterum Therapeutics plc raised to date?

Minus sign iconPlus sign icon As of September 2024, Iterum Therapeutics plc has raised $35M in funding. The last funding round occurred on Feb 03, 2021 for $35M.

When was Iterum Therapeutics plc founded?

Minus sign iconPlus sign iconIterum Therapeutics plc was founded in 2015.
Iterum Therapeutics plc

Iterum Therapeutics plc

Pharmaceutical ManufacturingDublin, Ireland11-50 Employees

Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. For more information on Iterum Therapeutics please visit www.iterumtx.com.

✕

Access Insights for Iterum Therapeutics plc and Millions of Other Companies

Sign up for full access to Iterum Therapeutics plc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Harcourt Street Dublin 2, Dublin 2 IE
Website
iterumtx.com
Stock Symbol
ITRM
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $35M

    Iterum Therapeutics plc has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Feb 03, 2021 in the amount of $35M.

Section iconFunding & Financials

  • $35M

    Iterum Therapeutics plc has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Feb 03, 2021 in the amount of $35M.

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Iterum Therapeutics plc and Millions of Other Companies

Sign up for full access to Iterum Therapeutics plc information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.